Cetuximab / panitumumab
About one-third of all epithelial cancers express high levels of epidermal growth factor receptor (EGF-R). Expression of EGF-R in a tumor is an indicator of poor prognosis, decreased survival, and increased metastasis.
The side effects can be very serious and may include allergic reactions. Other more common side effects of cetuximab treatment includes acne-like rash and dry skin.